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aclyn McCarty, who devoted 
his life as a physician-scientist 
to studying infectious disease 
organisms, was best known for his 
part in the monumental discovery 
that DNA, rather than protein, 
constituted the chemical nature of 
a gene. Uncovering the molecular 
secret of the gene in question—that 
for the capsular polysaccharide of 
pneumococcal bacteria—led the way 
to studying heredity not only through 
genetics but also through chemistry, 
and initiated the dawn of the age of 
molecular biology. McCarty was the 
youngest and longest surviving member 
of the research team responsible for 
this feat, which also included Oswald T. 
Avery and Colin MacLeod; he died on 
January 2, 2005, from congestive heart 
failure.
McCarty was born in 1911 in South 
Bend, Indiana, the second of four 
sons of a branch manager for the 
Studebaker Corporation while it was 
still a ﬁ  rm for horse-drawn carriages. 
In his teens, McCarty set himself the 
goal of becoming a physician-scientist, 
and he pursued a successful strategy 
to prepare for admission to, and early 
success in, Johns Hopkins University 
Medical School. As an undergraduate 
at Stanford University, he presciently 
began his studies in the nascent ﬁ  eld 
of biochemistry, working with James 
Murray Luck on protein turnover 
in the liver. In 1937, he began his 
clinical training in pediatrics at the 
Harriet Lane Service at Johns Hopkins 
University. There McCarty developed 
a special interest in infectious 
diseases—in particular,  antibacterial 
sulfonamide drug treatments that 
were just entering medicine—which 
he subsequently pursued by moving 
to New York University to work with 
William Tillett. A National Research 
Council Fellowship in the medical 
sciences and an opening in Oswald T. 
Avery’s laboratory spurred his move to 
Rockefeller University in 1941.
At that time, research in the 
Avery laboratory was focused on the 
pneumococcal transformation, the 
heritable alteration of a pneumococcal 
strain from a nonvirulent rough form 
to a virulent smooth encapsulated 
form. McCarty’s arrival at the 
Rockefeller Institute in September 
1941 marked 13 years since this 
discovery, also known as the Grifﬁ  th 
phenomenon. Prior to this discovery, 
the 1920s had been marked by a 
medley of disparate observations on 
Streptococcus pneumoniae that seemed 
to involve an exchange of receptors 
among diverse bacteria either grown 
together in liquid media or exposed 
to various kinds of extracts and 
supernatants. With rare exception, 
the early researchers in this area were 
utterly confused about the distinction 
between genotype and phenotype. No 
single experiment was carried forward 
to conﬁ  rmation by other observers, so 
the entire ﬁ  eld of “para agglutination” 
was in some disrepute. 
However, in 1928, Fred Grifﬁ  th, 
a leader in public-health research 
in Britain, demonstrated that the 
conversion of one strain to another 
could happen in vivo in mice. Shortly 
after the publication of his results, 
they were conﬁ  rmed in several 
quarters, including Avery’s lab. The 
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analysis relied on serotyping: it was 
known that phenotypic differentiation 
of pneumoccocal groups could be 
diagnosed by their reactions with 
speciﬁ  c antisera, already recognized 
to reﬂ  ect chemically distinct capsular 
polysaccharides. Grifﬁ  th had neither 
the resources nor the inclination to 
purify and identify the responsible 
agent in pneumococcal extracts that 
induced the changes of serotype. But 
the phenomenon of transformation was 
at least vaguely understood to comprise 
an alteration of what we would now call 
genetic factors. 
Though interrupted, sometimes 
for years at a time, these studies 
were from 1928 onwards the 
centerpiece of Avery’s lab agenda. 
Around 1940, they were activated 
by Colin MacLeod’s efforts to purify 
the chemical agent responsible for 
changes of serotype—whether protein, 
nucleic acid, or some other class of 
molecule—and demonstrate that it 
was necessary and sufﬁ  cient to cause 
the Grifﬁ  th phenomenon. Studies 
on pneumococcal transformation 
were grossly burdened by a wide 
variety of variables, which needed to 
be controlled to allow quantitative 
estimation of transforming activity 
in extracts undergoing various stages 
of puriﬁ  cation. MacLeod, over a 
number of years of research, had 
resolved several thorny technical issues 
to render the experimental system 
somewhat more reliable as an assay 
for biological activity. By the time 
McCarty arrived at the Rockefeller 
University, Avery’s team had just about 
decided that the active reagent was 
not a protein. But what was it then? 
Could it be a soluble saccharide, RNA, 
or, least likely, DNA? The progress of 
this research over the next three years 
is beautifully described in McCarty’s 
memoir The Transforming Principle, 
written in the early 1980s [1].
As puriﬁ  cation progressed, exposure 
of extracts to crystalline RNase and to 
proteinase preparations helped Avery’s 
team determine that the biological 
activity of extracts was not dependent 
on RNA or protein. Crystalline 
DNase was not available until 1948, 
but biological activity was rapidly 
reduced by tissue extracts rich in 
DNase. McCarty’s arrival at Rockefeller 
University was also marked by another 
milestone, namely, the development 
of a diphenylamine reagent assay to 
positively correlate DNA with biological 
activity. It gradually became evident 
that the active material in puriﬁ  ed 
extracts had astonishingly high 
potency in micrograms of DNA that 
could consummate the pneumococcal 
transformation in vitro.
McCarty, MacLeod, and Avery 
wrestled with the standard of 
proof required to claim that they 
had accomplished pneumococcal 
transformation with highly puriﬁ  ed 
DNA from extracts. After much self-
inquiry, in 1944, they published in the 
Journal of Experimental Medicine that the 
active material was, indeed, DNA [2], 
bereft of protein or any other known 
polymer [3,4].
The vicissitudes of the acceptance 
of the concept that “genes are DNA” 
deserve the scholarly praise they 
have received [5,6]. The claim was, 
indeed, subject to a formidable, but 
predictable, round of organized 
skepticism. Some would say, even 
worse, that it was simply ignored, but 
that is manifestly untrue, at least in 
the case of the New York research 
institutions. The scientiﬁ  c community 
does not accept major scientiﬁ  c claims 
with ease, and in this case, there were 
challenges associated with research on 
S. pneumoniae, which made it especially 
difﬁ  cult to attract other investigators 
to pursue this research. To begin with, 
few people had the necessary expertise 
with this pathogen from a biological 
perspective—it was dangerous to work 
with, and at the same time, it was 
ﬁ  nicky to grow. In order to assay its 
virulence, one needed to use mice as a 
selective ﬁ  lter. Most critically lacking as 
corroboration was the examination of 
other phenotypic markers, besides the 
capsular polysaccharide, to determine 
the extent that the ﬁ  ndings on the 
gene for one pneumococcal antigen 
would apply to other metabolic markers 
of S. pneumoniae.
However, by 1953, inﬂ  uenced by 
the enormous impact of Watson and 
Crick’s bihelical structure of DNA, 
the majority of researchers had fully 
accepted the 1944 paper. In fact, 
one might say, formal proof that 
DNA encoded genetic material was 
approximated only much later by the 
laboratory synthesis of oligonucleotides, 
and by the demonstration of genetic 
material’s biological activity, for 
example, genes for tRNA or small DNA 
viruses. Long before this formal proof, 
most commentators had accepted the 
untrammeled heuristic value of the 
proposition that, indeed, genes were 
made of DNA.
Meanwhile, a physician-scientist 
through and through, McCarty turned 
his attention to diseases promoted 
by streptococci. So it happened that 
on the retirement of Homer Swift 
in 1946, McCarty was asked to head 
the laboratory established in 1922 to 
work on streptococci and rheumatic 
fever. This was the scientiﬁ  c home of 
Rebecca Lanceﬁ  eld, who developed the 
still powerful serological classiﬁ  cation 
of streptococci. From innumerable 
clinical observations, combined with 
Lanceﬁ  eld’s classiﬁ  cation, it was 
clear that acute rheumatic fever, a 
severe sterile inﬂ  ammatory condition 
affecting particularly the joints and the 
heart, was a complication of group A 
streptococcal pharyngitis, following the 
infection by several weeks. The causal 
chain of events still eludes us. McCarty 
attacked this problem by studying both 
the biology of group A streptococci 
and patients with acute rheumatic fever 
admitted to the Rockefeller Hospital.
Together with his students and 
collaborators, over the next 20 
years, McCarty’s work changed the 
understanding of the organism from 
a gram-positive streptococcus with a 
particular serological characteristic 
to one of the best characterized 
bacterial species. Work on bacterial 
cell-wall anatomy and chemistry was just 
beginning. His work led to the isolation 
of the streptococcal cell wall as a 
structural entity suitable for anatomic 
inspection by electronmicroscopy. 
Chemical dissection led to 
characterization of the group 
A–speciﬁ  c polysaccharide and the 
peptidoglycan, and the identiﬁ  cation of 
its serological speciﬁ  city in the terminal 
hexosamine. In order to prove this 
speciﬁ  city, he ﬁ  rst had to identify and 
purify a speciﬁ  c enzyme that cleaved 
hexosamine (a hexosaminidase) 
from a soil organism. Treating the 
polysaccharide with this enzyme 
abrogated its serological reactivity. 
McCarty further demonstrated 
the precise conﬁ  guration of the 
hexosamine linkage by synthesizing 
both α- and β-N-acetyl-glucosamine 
ovalbumin and showing that only the 
second reacted with group A antisera. 
A similar analytical strategy indicated 
that the polysaccharide of group C 
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streptococci differed by having a 
terminal β-N-acetyl galactosamine as 
the serological determinant.
In parallel, McCarty studied patients 
with rheumatic fever admitted to 
the Rockefeller Hospital as well as 
valuable specimen collections from 
military outbreaks of the disease 
during World War II. He and his 
collaborators found that antibody 
responses to several streptococcal 
antigens were signiﬁ  cantly higher 
in the group of individuals that 
developed acute rheumatic fever than 
in individuals with uncomplicated 
infection. However, the response 
to unrelated antigens, for instance, 
diphtheria toxoid, was not enhanced. 
He found that group A streptococci 
secreted unusually high amounts of 
DNase, and established a test for the 
detection of antibodies produced in 
response to this antigen. This led to the 
discovery that streptococci were able to 
produce multiple isozymes of DNase. 
He puriﬁ  ed human C-reactive protein 
through crystallization, produced a 
highly speciﬁ  c antiserum, and, using 
this much simpler and more sensitive 
test, found that C-reactive protein levels 
responded more rapidly and reliably 
than other inﬂ  ammatory markers 
and could serve as the most accurate 
indicator of rheumatic inﬂ  ammatory 
activity. Measuring C-reactive protein 
levels to detect inﬂ  ammation is routine 
now in medical practice.
In his later years, McCarty 
increasingly served as a statesman of 
the biomedical sciences. He served for 
14 years as the physician-in-chief of the 
Rockefeller University Hospital, and as 
a trusted adviser and the vice president 
of the Rockefeller University. Outside 
the university, his leadership was sought 
by the New York City Health Research 
Council, the Helen Hay Whitney 
Foundation, the Institute of Medicine 
(as a charter member), and numerous 
university visiting boards. For more 
than 40 years, as editor, he placed his 
stamp of excellence and integrity on 
the Journal of Experimental Medicine.
McCarty’s scientiﬁ  c interests and 
energy had a counterpart in his rich 
personal life. Along with his wife, 
Marjorie, McCarty had a wide circle of 
very close friends, both in the United 
States and abroad, who cherished his 
personal warmth, his low key, spare, and 
pragmatic character, his wit, and his 
wide-ranging intellect. He loved English 
literature, theater, and symphonies. 
He loved to wander the streets and 
the museums of the great cities of the 
world, particularly, Paris, New York, and 
London, and frequently visited overseas 
following his retirement. Moreover, he 
remained close to his family; the four 
brothers, living in different parts of the 
country, never failed to meet for annual 
reunions. McCarty lived a full life, and 
he continues to inspire all who knew 
him.  
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